SCHEMBL7013353

SCHEMBL7013353

CCOC(=O)c1cccn1-c1ccc(Cl)c(CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRB2 P47870 6/20 0.38
GABRA2 P47869 5/20 0.38
LMNA P02545 3/20 0.33
PDE4B Q07343 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
SLC16A3 O15427 1/20 0.32
SLC16A1 P53985 1/20 0.32
BDKRB2 P30411 1/20 0.32
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012296 0.89 POLB (0.38) POLBTDP1L3MBTL1SLC16A3SLC16A1
SCHEMBL7014975 0.82 NOTUM (0.31)
SCHEMBL7011250 0.80 GAA (0.39) SMN1; SMN2ALDH1A1L3MBTL1BDKRB2CYP1A2
SCHEMBL7012849 0.79 BDKRB2 (0.40) SMN1; SMN2POLBNPC1RAB9AALDH1A1
SCHEMBL7009643 0.79 BDKRB2 (0.38) LMNAPOLBALDH1A1MAPTBDKRB2
SCHEMBL7005740 0.79 BDKRB2 (0.41) SMN1; SMN2POLBNPC1RAB9AALDH1A1
SCHEMBL7010644 0.79 NOTUM (0.40) GABRB2GABRA2LMNAPDE4BNPC1
SCHEMBL8722561 0.79 BDKRB2 (0.36) POLBNPC1RAB9AKDM4EBDKRB2
SCHEMBL7009650 0.79 BDKRB2 (0.55) BDKRB2
SCHEMBL7009647 0.79 BDKRB2 (0.55) BDKRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0861243-B1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-11-12 EP disclosed
US-6344462-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-05 US disclosed
US-6100284-A ANTIALLERGENS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-08 US disclosed
US-6008229-A TREATING ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0861243-A1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-09-02 EP disclosed
WO-1997011069-A1 HETEROCYCLIC COMPOUNDS AS BRADYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-27 WO disclosed